Herbs affecting the central nervous system: Gingko, Kava, St. John's wort, and Valerian

Clinical Obstetrics and Gynecology

Volumn 44, Issue 4, 2001, Pages 824-835

  Assemi, Mitra ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BUSULFAN; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CLINDAMYCIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; DOCETAXEL; DOLASETRON MESILATE; ESTROGEN; GINKGO BILOBA EXTRACT; HERBACEOUS AGENT; KAVA EXTRACT; KETOCONAZOLE; LIDOCAINE; MACROLIDE; NEFAZODONE; ONDANSETRON; PARACETAMOL; PROGESTERONE; QUINIDINE; STATIN; UNINDEXED DRUG; VALERIAN; VENLAFAXINE; VINBLASTINE; VINCRISTINE;

AFFECTIVE NEUROSIS; ALZHEIMER DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERICUM PERFORATUM; LIVER TOXICITY; REVIEW; SIDE EFFECT; SKIN MANIFESTATION; TREATMENT INDICATION;

CENTRAL NERVOUS SYSTEM; GINKGO BILOBA; HUMANS; HYPERICUM; KAVA; MEDICINE, HERBAL; PHYTOTHERAPY; PLANT EXTRACTS; SAFETY; TREATMENT OUTCOME; VALERIAN;

EID: 0035202701     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-200112000-00020     Document Type: Review

References (52)

1. Herb market levels after five years of boom: 1999 sales in mainstream market up only 11% in first half of 1999 after 55% increase in 1998
2. Alzheimer's disease: Etiologies, pathophysiology, cognitive reserve, and treatment opportunities
3. Flavonoids are scavengers of superoxide anions
4. Lipoperoxidation induced by hydrogen peroxide in human erythrocyte membranes. 2. Comparison of the antioxidant effect of Ginkgo biloba extract (EGb 761) with those of water-soluble and lipid-soluble antioxidants
5. The gingko biloba extract (EGb 761) protects hippocampal neurons against cell death induced by β-amyloid
6. Ginkgo biloba for dementia
7. A placebo-controlled, double-blind, randomized trials of an extract of gingko biloba for dementia
8. Proof of efficacy of the gingko biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia
9. The efficacy of gingko for elderly people with dementia and age-associated memory impairment: New results of a randomized clinical trial
10. The effects of acute doses of standardized gingko biloba extract on memory and psychomotor performance in volunteers
11. Coma in a patient with Alzheimer's disease taking low-dose trazodone and gingko biloba
12. Efficacy of kava extract for treating anxiety: Systematic review and meta-analysis
13. Treatment of patients with anxiety. Double-blind study of kava preparation WS 1490 versus benzodiazepine
14. Relaxing kava tea could be impairing Hawaii drivers
15. Kava-drinking case ends in mistrial
16. Hepatitis associated with kava, a herbal remedy for anxiety
17. Kava hepatotoxicity
18. Myoglobinuria after ingestion of extracts of guarana, gingko biloba, and kava
19. St. John's wort for depression. A meta-analysis of well-defined clinical trials
20. St. John's wort for depression
21. St. John's wort for depression. A systematic review
22. Equivalence of St. John's wort extract (Ze 117) and fluoxetine: A randomized, controlled study in mild-moderate depression
23. Comparison of equivalence between the St. John's wort extract LoHyp-57 and fluoxetine
24. Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: A double-blind, randomized pilot study
25. Hypericum in seasonal affective disorder (SAD)
26. An open-label trial of St. John's wort (Hypericum perforatum) in obsessive-compulsive disorder
27. A pilot study of Hypericumperforatum for the treatment of premenstrual syndrome
28. St. John's wort extract: Dfficacy for menopausal symptoms of psychological origin
29. Adverse effects profile of the herbal antidepressant St. John's wort (Hypericum perforatum L.)
30. Adverse effects of herbal drugs in dermatology
31. Erythroderma associated with St. John's wort
32. Photooxidation of lens ot-crystallin by hypericin (active ingredient in St. John's wort)
33. St. John's wort and antidepressant drug interactions in the elderly
34. St. John's wort-venlafaxine interaction
35. A possible cause of cardiovascular collapse during anesthesia: Long-term use of St. John's wort
36. St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor
37. Pharmacokinetic interaction of digoxin with an herbal extract from St. John's wort (Hypericum perforatum)
38. Monograph on potential drug interactions with St. John's wort
39. Drug interaction between St. John's wort and cyclosporine
40. Correspondence
41. Indinavir concentrations and St. John's wort
42. Valerian root. Valeriana officinalis. Analytical, quality control, and therapeutic monograph
43. Valerian for insomnia: A systematic review of randomized clinical trials
44. Therapy of insomnia: Efficacy and tolerability of a Baldrian preparation
45. Baldrian versus oxazepam: Efficacy and tolerability in non-organic and non-psychiatric insomniacs. A randomized, double-blind, clinical comparative study
46. Critical evaluation of the effect of valerian extract on sleep structure and sleep quality
47. Cardiac complications and delirium associated with valerian root withdrawal